Matches in Nanopublications for { ?s ?p "[In the present study, we tested the hypothesis that inhibition of renal phosphodiesterase type 5 (PDE5) in patients with liver cirrhosis and ascites increases sodium excretion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP801027.RASRwVopVLXPmGAhvI0ldCdDtlaRcObkvelT63OVOX_10130_assertion description "[In the present study, we tested the hypothesis that inhibition of renal phosphodiesterase type 5 (PDE5) in patients with liver cirrhosis and ascites increases sodium excretion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801027.RASRwVopVLXPmGAhvI0ldCdDtlaRcObkvelT63OVOX_10130_provenance.
- assertion description "[In the present study, we tested the hypothesis that inhibition of renal phosphodiesterase type 5 (PDE5) in patients with liver cirrhosis and ascites increases sodium excretion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP473844.RALqvJHnx8zpeyb8CnYnz84_ofj9R5ZJiLLcwRLK-1RYQ130_assertion description "[In the present study, we tested the hypothesis that inhibition of renal phosphodiesterase type 5 (PDE5) in patients with liver cirrhosis and ascites increases sodium excretion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP473844.RALqvJHnx8zpeyb8CnYnz84_ofj9R5ZJiLLcwRLK-1RYQ130_provenance.
- NP473845.RAKXXDDSL21Pq3u18_5Osi4Klt_x8JJEd2kk8q93AVzCQ130_assertion description "[In the present study, we tested the hypothesis that inhibition of renal phosphodiesterase type 5 (PDE5) in patients with liver cirrhosis and ascites increases sodium excretion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP473845.RAKXXDDSL21Pq3u18_5Osi4Klt_x8JJEd2kk8q93AVzCQ130_provenance.
- NP801063.RA5UKpxO-0Z4LF_078LGqoxdLR_5NP-WYxtzWPB8SnAZY130_assertion description "[In the present study, we tested the hypothesis that inhibition of renal phosphodiesterase type 5 (PDE5) in patients with liver cirrhosis and ascites increases sodium excretion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801063.RA5UKpxO-0Z4LF_078LGqoxdLR_5NP-WYxtzWPB8SnAZY130_provenance.